A mycelial membrane paper-based wearable sensor and its application and detection method

Through the mycelial membrane paper-based wearable sensor combined with the CRISPR/Cas12a system, the target nucleic acid aptamer in sweat triggers the reaction of the probe with the CRISPR/Cas12a system, solving the interference of existing drug detection methods by relying on expensive equipment and biological matrix. Problem, high sensitivity and high specificity drug detection is achieved, and the accuracy and stability of the detection are improved due to the antibacterial and physical adsorption ability of the Cordyceps mycelium membrane loaded with silver nanosheets.

CN117821233BActive Publication Date: 2024-11-15NAN JING SHI FAN DA XUE CHANG ZHOU HE CHENG SHENG WU XUE CHAN YE YAN JIU YUAN YOU XIAN GONG SI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410207459.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-02-26
Publication Date
2024-11-15
Estimated Expiration
2044-02-26

AI Technical Summary

Technical Problem

Existing drug detection methods rely on expensive equipment and are susceptible to biological matrix interference, resulting in low accuracy.

Method used

Using a mycelium membrane paper-based wearable sensor, combined with the CRISPR/Cas12a system, the target nucleic acid aptamer triggers the reaction of the target nucleic acid aptamer in the sweat to generate a fluorescent signal for detection, and uses a pupa loaded with silver nanosheets. Cordyceps mycelium membrane serves as a reaction chamber carrier to achieve non-invasive monitoring.

Benefits of technology

Drug detection with high sensitivity and high specificity is achieved, reducing dependence on expensive equipment, and the accuracy and stability of the detection are improved due to the physical adsorption ability and antibacterial properties of the mycelium membrane.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117821233B_ABST
    Figure CN117821233B_ABST
Patent Text Reader

Abstract

The present invention relates to the field of biomedical detection technology, and discloses a mycelial membrane paper-based wearable sensor and its application and detection method, comprising a paper base and a mycelial membrane layer, wherein an inner sinking groove and a reaction chamber are arranged on the surface of the mycelial membrane layer, and the paper base is assembled in the inner sinking groove; the paper base comprises a platform area on which a target nucleic acid aptamer trigger probe is drop-coated, and a reaction channel and a liquid inlet channel connected to the platform area, the end of the reaction channel is connected to the reaction chamber, a CRISPR / Cas12a system reagent is embedded in the reaction chamber, an inlet is opened on the mycelial membrane layer, and the inlet is connected to the liquid inlet channel, and the mycelial membrane paper-based wearable sensor can be attached to the surface of human skin and is used to detect chemical substances in sweat.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical detection technology, and in particular to a mycelium membrane paper-based wearable sensor and an application and detection method thereof. Background Art

[0002] Cocaine can easily cause strong psychological dependence, and also has a certain degree of physical dependence. Generally, cocaine can cause dependence after a few weeks of use, and severe cases will cause insomnia, loss of appetite, nausea, and digestive system disorders. Drug addicts will send large doses of cocaine into their bodies in a short period of time, causing chronic or acute poisoning. Amphetamine drugs can effectively stimulate the central nervous system, stimulate emotions, induce happiness, increase alertness and energy, reduce fatigue and appetite, increase movement and speech, and improve personal strength and ability, which seriously endangers human health and social security. Therefore, it is necessary to detect cocaine and methamphetamine with high sensitivity and specificity.

[0003] Commonly used instrumental drug detection methods include gas chromatography (GC), gas chromatography-mass spectrometry (GC-MS), high-performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (LC-MS), high-performance thin-layer chromatography (HPTLC), capillary electrophoresis (CE), and immunoassay (IA). Although these methods offer excellent sensitivity, they rely heavily on expensive equipment and complex detection protocols. In addition, they are still susceptible to interference from biological matrices, leading to inaccurate results.

[0004] Wearable sensing technology can continuously monitor an individual's health status and is crucial to achieving personalized medicine. The CRISPR-Cas system has also received widespread attention in the field of detection due to its remarkable sensitivity and specificity. Human sweat is rich in a large number of potential markers related to health and disease. Compared with conventional blood and urine tests, it has the advantages of non-invasiveness and real-time continuous monitoring. Therefore, how to combine wearable sensing technology and the CRISPR-Cas system to monitor analytes in sweat in a non-invasive manner is also one of the research directions in recent years. Summary of the invention

[0005] The purpose of the present invention is to provide a mycelium membrane paper-based wearable sensor and its application and detection method, so as to solve the problem that the existing technology for drug detection needs to rely on expensive equipment and is easily interfered by biological matrices and has low accuracy.

[0006] In order to solve the above technical problems, the present invention specifically provides the following technical solutions:

[0007] A mycelium membrane paper-based wearable sensor comprises a paper base layer and a mycelium membrane layer, an inner sinking groove and a reaction chamber are arranged on the surface of the mycelium membrane layer, and the paper base layer is assembled in the inner sinking groove;

[0008] The paper base layer includes a platform area on which a target nucleic acid aptamer trigger probe is drop-coated, and a reaction channel and a liquid inlet channel connected to the platform area. The end of the reaction channel is connected to the reaction chamber, and CRISPR / Cas12a system reagents are embedded in the reaction chamber. An inlet is opened on the mycelium film layer, and the inlet is connected to the liquid inlet channel. Sweat inhaled along the inlet reacts with the target nucleic acid aptamer trigger probe and the CRISPR / Cas12a system reagents in sequence to generate a fluorescent signal.

[0009] Furthermore, two reaction chambers are provided, and each of the reaction chambers is connected to the platform area through a reaction channel.

[0010] Furthermore, the target nucleic acid aptamer trigger probe is combined with the metal skeleton uio-66-NH2 to form an aptamer fixed unit cDNA-COOH-Apt@Uio-66-NH2, and is drop-coated on the platform area.

[0011] Further, cDNA-COOH-Apt@Uio-66-NH2 was obtained by:

[0012] Take 20 μM target nucleic acid aptamer solution and 20 μM target cDNA solution and react them in a 95°C water bath for 5 min, cool to room temperature to obtain cDNA-COOH-Apt, then add a mixed solution containing 400 nM EDC and 100 nM NHS, react at room temperature for 1 h to obtain a reaction solution, then add 1 mg / mL Uio-66-NH2 solution dispersed in ultrasound in advance and react with the reaction solution at room temperature for 3 h, centrifuge the reaction product, and rinse with 10 mM PBS (PH 7.4) to obtain;

[0013] Among them, the volume ratio of the target nucleic acid aptamer solution, the target cDNA solution, the mixed solution and the Uio-66-NH2 solution is 1:1:20:4.

[0014] Furthermore, the mycelium membrane layer is a Cordyceps militaris mycelium membrane loaded with silver nanosheets.

[0015] Furthermore, the Cordyceps militaris mycelium membrane loaded with silver nanosheets is obtained by the following method:

[0016] The Cordyceps militaris mycelium membrane was placed in a 1.5 mg / mL silver nanosheet solution, adsorbed overnight and then dried.

[0017] Furthermore, sucrose is also arranged on the reaction channel. The sucrose is dripped on the reaction channel in the form of a solution and is solidified by baking.

[0018] Furthermore, the CRISPR / Cas12a system reagent is embedded in the reaction chamber in the form of a lyophilized powder after rapid freezing and low-temperature drying, and the CRISPR / Cas12a system reagent includes Cas12a-CrRNA, NEBuffer2.1 buffer and a fluorescent probe, and the NEBuffer 2.1 buffer is mainly composed of NaCl, Tris-HCl, MgCl2 and BSA. After the reaction chamber is filled with sweat, the concentration of Cas12a-CrRNA in the reaction chamber is 20nM, the concentration of the fluorescent probe is 4μM, the concentration of NaCl is 10mM, the concentration of Tris-HCl is 5mM, the concentration of MgCl2 is 1mM, and the concentration of BSA is 10μg / mL.

[0019] The above-mentioned mycelium membrane paper-based wearable sensor can be attached to the surface of human skin and used to detect chemicals in sweat.

[0020] The present invention also provides a method for detecting chemical substances in sweat using the mycelial membrane paper-based wearable sensor, comprising the following steps:

[0021] Step 1: attaching the mycelial membrane paper-based wearable sensor to the surface of human skin;

[0022] Step 2: The sweat is absorbed by the paper substrate along the inlet and diffuses to the platform area, so that the sweat can react with the target nucleic acid aptamer trigger probe;

[0023] Step 3, allowing the reaction product of step 2 to flow into the reaction chamber along with sweat and react with the CRISPR / Cas12a system reagent;

[0024] Step 4: Determine whether the target object exists in the sweat based on whether the reaction chamber generates a fluorescent signal under the ultraviolet light.

[0025] Compared with the prior art, the present invention has the following beneficial effects:

[0026] The present invention combines wearable sensing technology with the CRISPR-Cas system to detect analytes in sweat in a non-invasive manner. At the same time, the wearable sensor in the present invention uses mycelium membrane as a carrier of the reaction chamber. The surface of the mycelium membrane has physical adsorption capacity and can adsorb fluorescent probes, thereby stabilizing the fluorescent data. It has good air permeability and strong antibacterial properties. It relies on the viscosity of the mycelium membrane itself and can be self-adsorbed on the human body surface without the need for additional adhesives when used. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] In order to more clearly illustrate the implementation methods of the present invention or the technical solutions in the prior art, the following briefly introduces the drawings required for the implementation methods or the description of the prior art. Obviously, the drawings in the following description are only exemplary, and for ordinary technicians in this field, other implementation drawings can be derived from the provided drawings without creative work.

[0028] Figure 1 A schematic diagram of the three-dimensional structure of a mycelium film paper-based wearable sensor patch provided in an embodiment of the present invention;

[0029] Figure 2 A schematic plan view of a mycelium membrane paper-based wearable sensor patch provided in an embodiment of the present invention;

[0030] Figure 3 The antibacterial ability diagram of different samples provided in the embodiments of the present invention;

[0031] Among them, Ⅰ is blank-drug-sensitive paper, Ⅱ is blank-hyphae membrane, Ⅲ is drug-sensitive paper-silver nanosheet, and Ⅳ is mycelium membrane-nanosheet;

[0032] Figure 4 The embodiment of the present invention provides Figure 3 Statistical graph of inhibition zone sizes of Ⅲ and Ⅳ;

[0033] Figure 5 A diagram showing the biocompatibility of mycelial membranes provided by an embodiment of the present invention;

[0034] Figure 6 This is a diagram showing the effects of different sucrose concentrations in the paper base provided by the embodiments of the present invention;

[0035] Figure 7 A viscosity diagram of mycelial membranes provided by an embodiment of the present invention on three different materials: glass, paper, and plastic;

[0036] Figure 8 This is a diagram showing the adsorption effect of the mycelium membrane on the fluorescent probe provided by an embodiment of the present invention.

[0037] Reference numerals:

[0038] 1. Paper base layer; 2. Mycelium membrane layer; 3. Entrance; 4. Channel area; 5. Reaction chamber; 6. Platform area. DETAILED DESCRIPTION

[0039] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0040] The following first describes the concepts involved in the present application in conjunction with the accompanying drawings. It should be noted that the following description of each concept is only to make the content of the present application easier to understand, and does not limit the scope of protection of the present application; at the same time, the embodiments and features in the embodiments of the present application can be combined with each other in the absence of conflict. The present application will be described in detail with reference to the accompanying drawings and in conjunction with the embodiments.

[0041] like Figure 1 and Figure 2 As shown, the present invention discloses a mycelium film paper-based wearable sensor, comprising a paper base layer 1 and a mycelium film layer 2, wherein an inner sinking tank and a reaction chamber 5 are provided on the surface of the mycelium film layer 2, and the paper base layer 1 is assembled in the inner sinking tank;

[0042] The paper base layer 1 includes a platform area 6 on which a target nucleic acid aptamer trigger probe is drop-coated, and a reaction channel 4 and a liquid inlet channel connected to the platform area 6. The end of the reaction channel 4 is connected to the reaction chamber 5, and the CRISPR / Cas12a system reagent is embedded in the reaction chamber 5. An inlet 3 is opened on the mycelium film layer 2, and the inlet 3 is connected to the liquid inlet channel. The sweat inhaled along the inlet 3 reacts with the target nucleic acid aptamer trigger probe and the CRISPR / Cas12a system reagent in sequence to generate a fluorescent signal.

[0043] The mycelium membrane paper-based wearable sensor is attached to the surface of human skin and is used to detect chemical substances in sweat, which specifically includes the following steps:

[0044] Step 1: attaching the mycelial membrane paper-based wearable sensor to the surface of human skin;

[0045] Step 2: The sweat is sucked into the paper base layer 1 along the inlet 3 and diffuses to the platform area 6, so that the sweat can react with the target nucleic acid aptamer trigger probe;

[0046] Step 3, allowing the reaction product of step 2 to flow into the reaction chamber 5 along with the sweat and react with the CRISPR / Cas12a system reagent;

[0047] Step 4: Determine whether the target object exists in the sweat based on whether the reaction chamber generates a fluorescent signal under the ultraviolet light.

[0048] During actual detection, multiple components can also be detected at the same time. For example, two reaction chambers 5 are provided, each of which is connected to the platform area 6 through a reaction channel 4. Corresponding CRISPR / Cas12a system reagents are arranged in each reaction chamber 5. Multiple target nucleic acid aptamer trigger probes can be dripped on the platform area at the same time. cDNA has a specific sequence and will only bind to a specific CrRNA.

[0049] When used for methamphetamine and cocaine detection, we performed quantitative detection of cocaine and methamphetamine. The primer sequences, crRNA sequences and fluorescent probe sequences are shown in Table 1:

[0050] Table 1 Primer sequences, crRNA sequences and fluorescent probe sequences

[0051]

[0052] Considering that the pure target nucleic acid aptamer trigger probe diffuses and penetrates the solution on the paper base after drop coating, and the adsorption amount is small, in the present invention, the target nucleic acid aptamer trigger probe is preferably loaded on the metal skeleton uio-66-NH2 to form an aptamer fixed unit cDNA-COOH-Apt@Uio-66-NH2, and drop coated on the platform area 6.

[0053] Specifically, the CRISPR / Cas12a system reagent is embedded in the reaction chamber in the form of a lyophilized powder after rapid freezing and low-temperature drying, and the CRISPR / Cas12a system reagent includes Cas12a-CrRNA, NEBuffer 2.1 buffer and a fluorescent probe, and the NEBuffer 2.1 buffer is mainly composed of NaCl, Tris-HCl, MgCl2 and BSA. After the reaction chamber is filled with sweat, the concentration of Cas12a-CrRNA in the reaction chamber is 20nM, the concentration of the fluorescent probe is 4μM, the concentration of NaCl is 10mM, the concentration of Tris-HCl is 5mM, the concentration of MgCl2 is 1mM, and the concentration of BSA is 10μg / mL.

[0054] cDNA-COOH-Apt@Uio-66-NH2 was obtained by the following method:

[0055] Take 20 μM target nucleic acid aptamer solution and 20 μM target cDNA solution and react them in a 95°C water bath for 5 minutes, cool to room temperature to obtain cDNA-COOH-Apt, then add a mixed solution containing 400 nM EDC and 100 nM NHS, react at room temperature for 1 hour, then add 1 mg / mL Uio-66-NH2 solution dispersed in ultrasound in advance and cDNA-COOH-Apt to react at room temperature for 3 hours, centrifuge the reaction product, and rinse with 10 mM PBS (PH 7.4).

[0056] Among them, the volume ratio of the target nucleic acid aptamer solution, the target cDNA solution, the mixed solution and the Uio-66-NH2 solution is 1:1:20:4.

[0057] Uio-66-NH2 is an existing metal skeleton that can be purchased from the market or synthesized by itself. In a specific embodiment, the preparation of Uio-66-NH2 includes the following steps: add 35 mL DMF (dimethylformamide), 0.08156 g zirconium tetrachloride and 0.06388 g 2-aminoterephthalic acid to a 50 mL high-pressure reactor, then add 4.2 mL acetic acid, stir evenly and react at 120 ° C for 24 hours. Cool to room temperature, take out the product and centrifuge, remove the supernatant, add 15 mL DMF for washing, centrifuge, and repeat three times. Finally, place in a vacuum drying oven at 100 ° C for 12 hours.

[0058] After synthesizing Uio-66-NH2, prepare cDNA-COOH-Apt@Uio-66-NH2: first, take 25μL of 20μM aptamer and 25μL of 20μM cDNA and react them in a 95℃ water bath for 5min, cool to room temperature, and obtain cDNA-COOH-Apt. Then add 500μL of 400nM EDC and 100nM NHS, and then react at room temperature for 1h, then react 100μL of 1mg / mL Uio-66-NH2 dispersed in ultrasound in advance with cDNA-COOH-Apt at room temperature for 3h, and finally centrifuge and rinse three times with 10mM PBS (PH 7.4).

[0059] The paper base layer can generally be made of paper with a certain adsorption effect, such as Whatman 4 (a fast absorbent paper). When using it, it can be cut into the required shape.

[0060] Considering that if the target in the sweat entering the platform area enters the reaction chamber 5 before fully reacting with the aptamer in the platform area 6, the number of cDNA entering the reaction chamber 5 will be too small, and the cDNA bound to the CrRNA will be too small, resulting in low fluorescence intensity, which may produce a negative reaction and affect the accuracy and sensitivity of the detection. Therefore, after the cDNA-COOH-Apt@Uio-66-NH2 is dripped, sucrose can also be set on the reaction channel 4. The sucrose is dripped on the reaction channel 4 in the form of a solution and cured by baking. It is placed in an oven and baked at 37°C for 1 hour. When the sweat enters the reaction channel, the sucrose can be slowly dissolved, thereby opening the reaction channel within a preset time.

[0061] like Figure 7 As shown, the present invention uses a microfluidic pump to simulate the outflow of sweat to optimize the dissolution rate of sucrose in the prepared paper-based sensor. As shown in the figure, at 2-2.5 mg / mL, it can reach about 30 minutes, which can meet our requirements. Therefore, the concentration of the drop-coated sucrose solution is preferably 2-2.5 mg / mL.

[0062] The mycelium membrane layer 2 in the present invention can be any biomembrane with air permeability and antibacterial properties, but considering the formability of the mycelium membrane, it is preferably a Cordyceps militaris mycelium membrane loaded with silver nanosheets, which can be prepared into any shape.

[0063] The present invention explores the ability of mycelial membrane to resist Staphylococcus aureus under the conditions of different concentrations of silver nanosheets. Figure 3 and Figure 4 As shown: the concentration of silver nanosheets increases from 0.1 mg / mL to 2 mg / mL. At 1.5 mg / mL, the inhibition zone reaches its maximum, and there is no increase in the zone afterwards.

[0064] Therefore, the Cordyceps militaris mycelium membrane loaded with silver nanosheets is preferably obtained by the following method:

[0065] The Cordyceps militaris mycelium membrane was placed in a 1.5 mg / mL silver nanosheet solution, adsorbed overnight and then dried.

[0066] Furthermore, the present invention conducted experiments on the biocompatibility of Cordyceps militaris mycelial membranes. Figure 5 As shown, cell experiments were conducted on pure mycelial membrane and mycelial membrane + silver nanosheets, and the MTT experiment specifically included:

[0067] (1) Wash Hela cells with sterile PBS buffered saline, add trypsin for digestion, and dilute the cell suspension to a concentration of 6×10 4 / mL, inoculated in 96-well plates, 100 µL per well, added 200 µL PBS buffer at the periphery, cultured in a constant temperature cell culture incubator for 24 hours to allow the cells to fully adhere to the wall, and observed under a microscope.

[0068] (2) Prepare solutions with concentrations of 0, 10, 50, 100, 1000, 5000, and 10000 μg / mL for mycelial membranes. After the cells attach to the wall, add 100 μL of drug solutions of different concentrations to the wells except the outermost circle. Add 100 μL of blank culture medium as a blank control group and continue to culture in the incubator for 48 hours. Add 20 μL of MTT solution to each well, then place it in a cell culture incubator and continue to culture.

[0069] (3) After terminating the culture, remove the 96-well plate, discard the liquid in the wells, add 150 μL DMSO to each well, and shake at 100 rpm for 10 min in a 37°C shaker. Use an ELISA reader (detection wavelength 490 nm) to measure the absorbance of each well.

[0070] The results show that at 10000 μg / mL, the cell activity is less than 80% of that at 0 μg / mL, so the mycelial membrane has no cytotoxicity and has good biocompatibility.

[0071] like Figure 6 As shown, the present invention also conducted a comparative experiment on the air permeability of Cordyceps militaris mycelium membrane and the air permeability of Cordyceps militaris mycelium membrane-silver nanosheets by increasing the mass of the desiccant (80wt% CaCl2+ 20wt% magnesium sulfate) in a bottle sealed by the corresponding materials.

[0072] The specific method is as follows: 80 g CaCl2 and 20 g MgSO4 were dried in an oven for 6 hours, then ground into powder in a mortar and evenly distributed into conical flasks for later use. The mycelial membrane and silver nanosheets @ mycelial membrane composites were cut into the same size and used to seal conical flasks. Water vapor penetrates into the membrane material and is absorbed by the desiccant, resulting in weight increase over time. During the experiment, the mass of the conical flask was weighed every hour and its weight gain was recorded), as shown in the following table, which shows three groups of mycelial membranes and three groups of silver nanosheets @ mycelial membrane composites from top to bottom. The final air permeability of this experiment was 1600g / (m 2 *h) and above, good air permeability.

[0073]

[0074]

[0075] In addition to its own biocompatibility, antibacterial and breathable properties, the mycelial membrane of Cordyceps militaris used in the present invention also has the effects of self-adhesion and fluorescent probe adsorption when applied to the field of wearable sensors. Specifically: the mycelial membrane in the present invention is mainly composed of substances such as polysaccharides, proteins and polysaccharides. Since there is physical adsorption between protein biomass, such as Figure 7 As shown, it can be adsorbed between glass, paper, plastic and human skin.

[0076] In addition, the present invention adds a fluorescent probe to the prepared mycelial membrane, incubates for 1 hour, then washes it with water 2 times, 5 times, and 10 times and observes it under a fluorescent microscope to determine the adsorption capacity of the mycelial membrane. Figure 8 As shown, the surface of the mycelium membrane has physical adsorption capacity, which can adsorb the fluorescent probe, so that it will not easily leave with the water due to washing. Thus, the fluorescence data is stabilized. During sweat testing, the fluorescent probe will not disperse with the flow of sweat, and the fluorescence data will be fixed to ensure the sensitivity and accuracy of the test.

[0077] It should be noted that the terms used in this application are only for describing specific embodiments, rather than limiting the scope of this application. As shown in the specification of this application, unless the context clearly indicates an exception, the words "one", "a", "a kind of" and / or "the" do not specifically refer to the singular, but may also include the plural. The terms "include", "comprise" or any other variant thereof are intended to cover non-exclusive inclusion, so that the process, method or device including a series of elements includes not only those elements, but also includes other elements not explicitly listed, or also includes elements inherent to such process, method or device. In the absence of further restrictions, the elements defined by the statement "include one..." do not exclude the presence of other identical elements in the process, method or device including the elements.

[0078] It should also be noted that the terms "center", "up", "down", "left", "right", "vertical", "horizontal", "inside", "outside", etc., indicating the orientation or position relationship, are based on the orientation or position relationship shown in the drawings, and are only for the convenience of describing the present application and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as a limitation on the present application. Unless otherwise clearly specified and limited, the terms "installed", "connected", "connected", etc. should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection, or it can be an indirect connection through an intermediate medium, or it can be a connection between the two elements. For those of ordinary skill in the art, the specific meanings of the above terms in this application can be understood according to specific circumstances.

[0079] The embodiments and / or implementation methods described above are only used to illustrate the preferred embodiments and / or implementation methods for realizing the technology of the present invention, and are not intended to limit the implementation methods of the technology of the present invention in any form. Any technical personnel in this field may make slight changes or modifications to other equivalent embodiments without departing from the scope of the technical means disclosed in the content of the present invention, but they should still be regarded as technologies or embodiments that are essentially the same as the present invention.

[0080] This article uses specific examples to illustrate the principles and implementation methods of this application. The description of the above embodiments is only used to help understand the method and its core ideas of this application. The above is only the preferred implementation method of this application. It should be pointed out that due to the limitations of textual expression and the objective existence of infinite specific structures, ordinary technicians in this technical field can make several improvements, modifications or changes without departing from the principles of this application, and can also combine the above technical features in an appropriate manner; these improvements, modifications, changes or combinations, or the direct application of the concept and technical solution of the invention to other occasions without improvement, should be regarded as the scope of protection of this application.

Claims

1. A mycelial membrane paper-based wearable sensor, characterized in that: It comprises a paper base layer (1) and a mycelium membrane layer (2), an inner sedimentation tank and a reaction chamber (5) are arranged on the surface of the mycelium membrane layer (2), and the paper base layer (1) is assembled in the inner sedimentation tank; The paper base layer (1) comprises a platform area (6) on which a target nucleic acid aptamer trigger probe is drop-coated, and a reaction channel (4) and a liquid inlet channel connected to the platform area (6); the end of the reaction channel (4) is connected to the reaction chamber (5); a CRISPR / Cas12a system reagent is embedded in the reaction chamber (5); an inlet (3) is provided on the mycelium film layer (2); the inlet (3) is connected to the liquid inlet channel; sweat inhaled along the inlet (3) reacts with the target nucleic acid aptamer trigger probe and the CRISPR / Cas12a system reagent in sequence to generate a fluorescent signal; The mycelium membrane layer (2) is a Cordyceps militaris mycelium membrane loaded with silver nanosheets.

2. The mycelial membrane paper-based wearable sensor according to claim 1, characterized in that: Two reaction chambers (5) are provided, and each reaction chamber (5) is connected to the platform area (6) via a reaction channel (4).

3. The mycelial membrane paper-based wearable sensor according to claim 1, characterized in that: The target nucleic acid aptamer trigger probe is combined with the metal skeleton uio-66-NH2 to form an aptamer fixed unit cDNA-COOH-Apt@Uio-66-NH2, and is drop-coated on the platform area (6).

4. The mycelial membrane paper-based wearable sensor according to claim 3, characterized in that: cDNA-COOH-Apt@Uio-66-NH2 was obtained by the following method: Take 20 μM target nucleic acid aptamer solution and 20 μM target cDNA solution and react them in a 95°C water bath for 5 min, cool to room temperature to obtain cDNA-COOH-Apt, then add a mixed solution containing 400 nM EDC and 100 nM NHS, react at room temperature for 1 h to obtain a reaction solution, then add 1 mg / mL Uio-66-NH2 solution dispersed in ultrasound in advance and react with the reaction solution at room temperature for 3 h, centrifuge the reaction product, and rinse with 10 mM PBS (PH 7.4) to obtain; Among them, the volume ratio of the target nucleic acid aptamer solution, the target cDNA solution, the mixed solution and the Uio-66-NH2 solution is 1:1:20:

4.

5. The mycelial membrane paper-based wearable sensor according to claim 4, characterized in that: The Cordyceps militaris mycelium membrane loaded with silver nanosheets is obtained by the following method: The Cordyceps militaris mycelium membrane was placed in a 1.5 mg / mL silver nanosheet solution, adsorbed overnight and then dried.

6. The mycelial membrane paper-based wearable sensor according to claim 1, characterized in that: Sucrose is also provided on the reaction channel (4), and the sucrose is dripped onto the reaction channel (4) in the form of a solution and solidified by baking.

7. The mycelial membrane paper-based wearable sensor according to claim 1, characterized in that: The CRISPR / Cas12a system reagent is embedded in the reaction chamber in the form of a lyophilized powder after rapid freezing and low-temperature drying. The CRISPR / Cas12a system reagent includes Cas12a-CrRNA, NEBuffer 2.1 buffer and a fluorescent probe. The NEBuffer 2.1 buffer is mainly composed of NaCl, Tris-HCl, MgCl2 and BSA. After the reaction chamber is filled with sweat, the concentration of Cas12a-CrRNA in the reaction chamber is 20nM, the concentration of the fluorescent probe is 4μM, the concentration of NaCl is 10mM, the concentration of Tris-HCl is 5mM, the concentration of MgCl2 is 1mM, and the concentration of BSA is 10μg / mL.

8. An application of the mycelial membrane paper-based wearable sensor as claimed in claim 1, characterized in that: Attached to the surface of human skin, it is used for drug detection for non-therapeutic diagnostic purposes.

9. A method for using the mycelial membrane paper-based wearable sensor according to any one of claims 1 to 7 for drug detection for non-therapeutic diagnostic purposes, characterized in that: The steps include: Step 1: attaching the mycelial membrane paper-based wearable sensor to the surface of human skin; Step 2: sweat is absorbed by the paper base layer (1) along the inlet (3) and diffuses to the platform area (6), so that the sweat can react with the target nucleic acid aptamer trigger probe; Step 3, allowing the reaction product of step 2 to flow into the reaction chamber (5) along with the sweat and react with the CRISPR / Cas12a system reagent; Step 4: Determine whether the target object exists in the sweat based on whether the reaction chamber generates a fluorescent signal under the ultraviolet light.